LINC vs UTI

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 02, 2026

LINC

45.1
AI Score
VS
UTI Wins

UTI

46.2
AI Score

Investment Advisor Scores

LINC

45score
Recommendation
HOLD

UTI

46score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric LINC UTI Winner
Forward P/E 26.0417 27.248 LINC
PEG Ratio 1.7369 1.8142 LINC
Revenue Growth 22.4% 7.2% LINC
Earnings Growth 20.0% -78.9% LINC
Tradestie Score 45.1/100 46.2/100 UTI
Profit Margin 4.0% 3.9% LINC
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

LINC 1M: -8.8% · 3M: -57.6% UTI 1M: -8.7% · 3M: -60.6%

Current Technical Phase

LINC

Markdown
Sell / avoid

Price below a falling SMA50 (slope -25.4%), weak momentum, RSI 28

RSI (14): 27.9 · Price: $22.17

UTI

Markdown
Sell / avoid

Price below a falling SMA50 (slope -26.6%), weak momentum, RSI 32

RSI (14): 31.7 · Price: $19.03

Fundamentals Snapshot

Metric LINC UTI
Market Cap — —
Forward P/E 21.2 25.9
Trailing P/E 30.0 30.6
Revenue (TTM) — —
Revenue Growth 0.2% 0.1%
Gross Margin 0.6% 0.6%
Operating Margin 0.0% 0.0%
EPS 0.73 0.61
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, UTI is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.